Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer
Nom de la revue
Annals of Oncology
A.-S. Hamy, J.-Y. Pierga, A. Sabaila, E. Laas, H. Bonsang-Kitzis, C. Laurent, A. Vincent-Salomon, P. Cottu, F. Lerebours, R. Rouzier, M. Lae, F. Reyal
